Atlas Genetics Gains CE Approval for First Product
08 February 2016
Atlas Genetics Ltd ("Atlas Genetics" or the "Company"), the ultra-rapid Point-Of-Care (POC) molecular diagnostics company, today announces that it has received approval to CE Mark its Chlamydia trachomatis (CT) test to be launched on the Company's io® platform. By meeting the requirements of the IVD Directive (98/79/EC), the CT test is now cleared for sale within the European Union.
University of Bath biotech spin-out wins EU approval for ground-breaking chlamydia test
08 February 2016
A small biotech that started life at the University of Bath has won approval from European regulators to sell a device that tests for the sexually transmitted disease chlamydia in just 30 minutes.
Follow-on bonanza drives U.K. investment in life science stocks past £1B
08 February 2016
At first glance, 2015 looks like the year the London Stock Exchange turned its back on biotech once again. Acacia Pharma and Shield Therapeutics both tried and failed to be 2015's Circassia (LON:CIR), the big success story of 2014, leaving AIM listings and outliers such as PureTech (LON:PRTC) as the most notable London IPOs of the year. And yet, from another angle, 2015 looks like a landmark year.
Crick researchers get OK for gene editing on human embryos
08 February 2016
he U.K. regulator has given researchers at the Crick Institute in London permission to use CRISPR/Cas9 gene editing on human embryos, with the aim of understanding which genes are involved in successful early development.
New analyzer to identify dangerous viruses developed in Novosibirsk
08 February 2016
Researchers at Medical Biological Union (MBU), a biotech company in Novosibirsk, in Siberia, have come up with a new immune-enzyme test system that is said to be able to identify four of the world’s most dangerous viruses simultaneously, the Russian news agency TASS reported , citing Darya Popova, the developer’s head of marketing.
At MIPT, new cooling for next gen computers developed
08 February 2016
Physicists at Moscow’s MIPT, a leading Russian university focused on physics and technology, also known as Phystech, have developed a cooling system or the plasmon components of optoelectronic chips which are expected to run tens of thousands of times faster than today’s computers, the MIPT website announced.
Backed by a lineup of marquee VCs, Unity Biotechnology tackles the hard science of aging
05 February 2016
Imagine a drug that could clear away "senescent" cells and make the life span allotted to you longer and healthier, absent many of the myriad diseases that can accumulate with age. Some investigators have been working on that subject for more than a decade, and now a biotech is being launched to see if it can make that dream a reality.
Blockbuster new launches coming from Intercept, Gilead and Merck: Reuters
05 February 2016
The pharma industry heralded 11 new blockbusters in 2015, an act that's tough to follow. But while 2016 may not see quite that many, it's still on track to ring in 7 new therapies that have a shot at cracking the billion-dollar sales mark, a new analysis says.
Value, Validation Mark Upbeat State of Industry in Regenerative Medicine
05 February 2016
In delivering the Alliance for Regenerative Medicine’s (ARM) 2016 state of the industry briefing at the Biotech Showcase event this month in San Francisco, chair of the international advocacy organization representing the regenerative medicine and advanced therapies (RM/AT) community, Edward Lanphier, said 2015 had been a great year for the sector, exemplified by excellent clinical data readouts that have helped attract significant investments and big pharma validation through major partnerships.
FDA: Solution to drug prices not as simple as clearing generic backlog
05 February 2016
A backlog of generic drug applications is not to blame for escalating drug prices that have become standard fare for presidential campaigns and congressional hearings over the past few months.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024